# Intraoperative Margin Assessment During Mohs Surgery

> **NCT02750033** · — · WITHDRAWN · sponsor: **Seton Healthcare Family**

## Conditions studied

- Squamous Cell Carcinoma (SCC)
- Basal Cell Carcinoma (BCC)

## Interventions

- **DEVICE:** Multimodal Spectroscopy (MMS)

## Key facts

- **NCT ID:** NCT02750033
- **Lead sponsor:** Seton Healthcare Family
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Protocol changed to meet IRB requirements for patient safety
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02750033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02750033, "Intraoperative Margin Assessment During Mohs Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02750033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*